Condition

Malignant Neoplasms of Thyroid and Other Endocrine Glands

ClinicalTrials.gov condition label

Clinical trials4

Recruiting1

Common interventions8

Lead sponsors shown1

Clinical trials

4 shown

Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary MetastasesNCT03093909 · 2017-11-22

Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NTNCT03435952 · 2018-07-10

ACTIVE_NOT_RECRUITING

Selumetinib and Olaparib in Solid TumorsNCT03162627 · 2017-08-04

ACTIVE_NOT_RECRUITING

Lenvatinib and Capecitabine in Patients With Advanced MalignanciesNCT02915172 · 2016-12-01

Common interventions

CapecitabineDRUG1 Clostridium Novyi-NTBIOLOGICAL1 DoxycyclineDRUG1 GemcitabineDRUG1 LenvatinibDRUG1 OlaparibDRUG1 PembrolizumabDRUG1 SelumetinibDRUG1

Leading sponsors

M.D. Anderson Cancer Center4

Trial status mix

ACTIVE_NOT_RECRUITING2

RECRUITING1

WITHDRAWN1

Phase mix

PHASE14

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.